The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
about
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersIntegrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to FibrosisAXL is an oncotarget in human colorectal cancer.Targeting protein kinases to reverse multidrug resistance in sarcoma.Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.Gene of the month: Axl.Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?Antiviral Screening of Multiple Compounds against Ebola VirusSignificant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma.Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib.Targeting Gas6/TAM in cancer cells and tumor microenvironment.The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review.Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes.
P2860
Q28082793-9229F6E5-AA73-43B4-88E8-59096EFDD890Q33670296-CE6B3D20-CBD6-4C7E-9CFC-17A881D44A25Q33800254-B66DA4C9-DB9B-4634-8F5A-259BF0DB61BCQ36414168-61C55606-9372-4543-8F0C-11E84945DE36Q36527950-27495636-3F10-425C-A9E1-5B0CE055A0F3Q37376411-40169446-F987-4800-A9C3-0553CE2B5601Q38763966-7F7C49A4-89D4-4615-8445-88732CD2CF55Q38936702-FBFB9F8C-FD34-4DEE-8EF1-E91E0EA878F1Q39227786-85AADEE4-2F45-4FA2-9E69-C981CE46474EQ39996613-717810EE-6928-4BFD-8714-2FB02D0FF258Q42131196-C160E8FC-B36B-4019-9FD5-2C67C2E2BB93Q47148669-AB33E906-6EDA-411C-9EDF-603871B0AE7DQ47164935-4E57DFBF-9ABA-4C91-B392-BFD632BD20D8Q47701436-DD971FB4-AD3A-4D7D-AF64-7C4507014441Q49238007-438FD2FD-18AB-4BC8-8748-6217FB78FFAEQ50113702-868B554C-D711-4B3F-A321-69825A9D0593Q54978439-C8C1BCED-9B81-47C0-A9E5-40CCA2BAE5E7
P2860
The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@ast
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@en
type
label
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@ast
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@en
prefLabel
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@ast
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@en
P2093
P2860
P50
P356
P1433
P1476
The role of AXL and the in vit ...... ibitor BGB324 in Ewing sarcoma
@en
P2093
Melissa H S Hillebrandt-Roeffen
Otto C Boerman
Uta E Flucke
Winette T A van der Graaf
P2860
P304
12753-12768
P356
10.18632/ONCOTARGET.2648
P407
P577
2014-12-01T00:00:00Z